戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  relevant to the clinical pathophysiology of Miller Fisher syndrome.
2 as the potential to ameliorate the course of Miller Fisher syndrome.
3         Infectious illnesses usually precede Miller Fisher syndrome.
4 cquired neuromyotonia, Morvan's syndrome and Miller-Fisher syndrome.
5 ype O:10 was isolated from a patient who had Miller-Fisher syndrome.
6 antibodies in the diagnosis and causation of Miller-Fisher syndrome?
7 7 had GBS (18 demyelinating, 8 axonal, and 1 Miller Fisher syndrome), 5 had encephalitis (3 with conc
8 uscular transmission occurs in some cases of Miller Fisher syndrome and Guillain-Barre syndrome.
9 p a greater understanding of the spectrum of Miller Fisher syndromes and to refine clinical diagnoses
10             Ganglioside complexes in GBS and Miller-Fisher syndrome are frequently present and are mo
11                                              Miller Fisher syndrome-associated anti-GQ1b ganglioside
12 Guillain-Barre syndrome and its variant, the Miller Fisher syndrome, during TNFalpha antagonist thera
13 llain-Barre syndrome, the motor variant, and Miller Fisher syndrome from controls with high sensitivi
14 tinguished motor Guillain-Barre syndrome and Miller Fisher syndrome from controls, with antibodies to
15 ution of clinical features is reminiscent of Miller Fisher syndrome, in which acute-phase anti-disial
16                                              Miller Fisher syndrome is a localized variant of Guillai
17                                              Miller-Fisher syndrome is an autoimmune neuropathy chara
18 tibodies are the serological hallmark of the Miller Fisher syndrome (MFS) variant of the paralytic ne
19  MR also facilitates differentiation between Miller-Fisher Syndrome (MFS) and BBE in cases of diagnos
20 ggering of Guillain-Barre syndrome (GBS) and Miller-Fisher syndrome (MFS) following C. jejuni infecti
21  in the triggering of the Guillain-Barre and Miller-Fisher syndrome neuropathies after C. jejuni infe
22 ts of the Guillain-Barre syndrome, including Miller-Fisher syndrome, subsets of immunoglobulin M para
23 atient with rheumatoid arthritis in whom the Miller Fisher syndrome variant of the Guillain-Barre syn
24  were included in the analyses, and cases of Miller Fisher syndrome were excluded.
25 atients with chronic ataxic neuropathies and Miller Fisher syndrome were studied.
26 nding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the mo